Investor Relations
Notice regarding the nomination and candidacy for the replacement of an Independent Board Member
Nomination/candidacy application form, CV of nominees
Notice of the Annual General Meeting of Shareholders 2020
Confirmation paper or Power of Attorney to attend the AGM 2020
List of documents at the AGM 2020
Contents and projected agenda at the AGM 2020 of DHG Pharma
Regulation on organizing the AGM 2020 at DHG Pharma
Report of the Board of Directors
Report of Audit Committee 2020
Audited consolidated financial statements FY 2020
Statement on the profit distribution 2020 and the profit distribution plan 2021
Statement on supplements and amendments to the Charter, the Internal Regulation on Corporate Governance, and the Operational Reg
Charter, Internal Regulation on Corporate Governance, BOD Regulation
Supplements and amendments to DHG Pharma’s Charter
Supplements and amendments to the Internal Regulation on Corporate Governance
Supplements and amendments to the Operational Regulation of the Board of Directors
Statement on the dismissal of an Independent Board Member and election of an Independent Board Member
Election regulation for the replacement of an Independent Board Member
Election ballot for the Independent Board Member as a replacement
Voting ballot at the AGM 2020
Draft Resolution of the AGM 2020
Notice of the Annual General Meeting of Shareholders 2019
Proposed contents and agenda at the AGM 2019
List of documents at the Annual General Meeting of Shareholders 2019
Meeting agenda, working regulations and voting rules
Report of the Board of Directors 2019 – business plan 2020
Report of Audit Committee 2019
Audited consolidated financial statement FY 2019
Statement on the profit distribution 2019 and the profit distribution plan 2020
Statement on the selection of an independent auditor for 2020 financial statements
Statement on supplementing the business lines of DHG Pharma and amending the Charter in accordance with the new supplementary business lines
Voting ballot at the Annual General Meeting of Shareholders 2019
Draft Resolution of the Annual General Meeting of Shareholders 2019.
Notice of the Annual General Meeting of Shareholders 2018
Confirmation paper or Power of Attorney to attend the Annual General Meeting of Shareholders 2018
Proposed contents and agenda at the Annual General Meeting of Shareholders 2018
List of documents at the Annual General Meeting of Shareholders 2018
Meeting agenda, working regulation and voting rule.
Report of the Board of Directors (BOD) Term III (2014 – 2018).
Report of the Board of Supervisory (BOS) Term III (2014 – 2018).
Audited consolidated financial statements 2018.
Statement regarding the profit distribution 2018 and the profit distribution plan 2019.
Statement regarding the selection of an independent auditor for 2019 financial statements.
The resignation letter from the Supervisor position of Ms. Nguyen Phuong Thao
Statement on the supplements and amendments of DHG Pharma’s business lines
Statement on changing organizational structure, management and control from the BOS model to the Audit Committee model under the BOD of DHG Pharma
Reference table on the amendments and supplements of the Charter of DHG Pharma
Reference table on the amendments and supplements of the Internal Regulation on Corporate Governance of DHG Pharma
Statement on the quantity and member structure of the BOD Term IV (2019 – 2023)
Statement on the nomination/candidacy list and curriculum vitae of candidates
Information related to the candidates for the BOD
Voting Rule of the BOD Term IV (2019 – 2023) of DHG Pharma
Election ballot for the BOD member Term IV (2019 – 2023) of DHG Pharma
Voting ballot at the Annual General Meeting of Shareholders 2018
Draft Resolution of the Annual General Meeting of Shareholders 2018
Notice regarding the candidacy and nomination of the Board of Directors’ members of DHG Pharma Term IV (2019 – 2023)
Candidacy/nomination application form to join the Board of Directors
Curriculum vitae of nominees for the Board of Directors
Declaration for the purpose of verifying independence and commitment of an independent BOD member